The anti-apoptosis function of: Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

EMBO Journal

Volumn 16, Issue 15, 1997, Pages 4628-4638

  Huang, David C S ^a   O'Reilly, Lorraine A ^a   Strasser, Andreas ^a   Cory, Suzanne ^a  

^a NONE

Author keywords

Apoptosis; Bcl 2; Bcl w; Bcl x(L); Cell cycle control

Indexed keywords

CELL PROTEIN; CYTOKINE; MUTANT PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DIMERIZATION; ETIOLOGY; GENE MUTATION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CONSERVED SEQUENCE; GENES, BCL-2; GENES, DOMINANT; GENES, P53; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RAS PROTEINS; RATS; TRANSFECTION;

ANIMALIA;

EID: 0030794452     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.15.4628     Document Type: Article

References (86)

1. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W. and Yuan, J. (1996) Human ICE/CED-3 protease nomenclature. Cell, 87, 171.
2. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
3. Borner, C. (1996) Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem., 271, 12695-12698.
4. Borner, C., Martinou, I., Mattmann, C., Irmler, M. Schaerer, E., Martinou, J.-C. and Tschopp, J. (1994) The protein bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol., 126, 1059-1068.
5. Boyd, J.M., Malstrom, S., Subramanian, T., Venkatesh, L.K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C. and Chinnadurai, G. (1994) Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell, 79, 341-351.
6. Boyd, J.M. et al. (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene, 11, 1921-1928.
7. Brady, H.J.M., Gil-Gómez, G., Kirberg, J. and Berns, A.J.M. (1996) Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO J., 15, 6991-7001.
8. Ras in Ras-induced apoptosis. J. Biol. Chem., 271, 2376-2379.
9. Chinnaiyan, A.M., O'Rourke, K., Lane, B.R. and Dixit, V.M. (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science, 275, 1122-1126.
10. Chiou, S.-K., Tseng, C.-C., Rao, L. and White, E. (1994) Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol., 68, 6553-6566.
11. Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., Chinnadurai, G. and Lutz, R.J. (1995a) A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J., 14, 5589-5596.
12. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I. and Guild, B.C. (1995b) Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736.
13. Cleary, M. and Rosenberg, S.A. (1990) The bcl-2 gene, follicular lymphoma, and Hodgkin's disease. J. Natl Cancer Inst., 82, 808-809.
14. Cory, S. (1995) Regulation of lymphocyte survival by the BCL-2 gene family. Annu. Rev. Immunol., 13, 513-543.
15. Cox, A.D., Brtva, T.R., Lowe, D.G. and Der, C.J. (1994) R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene, 9, 3281-3288.
16. Crissman, H.A., Darzynkiewicz, Z., Steinkamp, J.A. and Tobey, R.A. (1990) Simultaneous fluorescent labeling of DNA, RNA and protein. Methods Cell Biol., 33, 305-314.
17. Debbas, M. and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546-554.
18. Ellis, R.E., Yuan, J. and Horvitz, H.R. (1991) Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7, 663-698.
19. Fanidi, A., Harrington, E.A. and Evan, G.I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359, 554-556.
20. Farrow, S.N., White, J.H.M., Martinou, I., Raven, T., Pun, K.-T., Grinham, C.J., Martinou, J.-C. and Brown, R. (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature, 374, 731-733.
21. Fernandez-Sarabia, M.J. and Bischoff, J.R. (1993) Bcl-2 associates with the ras-related protein R-ras p23. Nature, 366, 274-275.
22. Fraser, A. and Evan, G. (1996) A license to kill. Cell, 85, 781-784.
23. Gibson, L. et al. (1996) bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene, 13, 665-675.
24. Grussenmeyer, T., Scheidtmann, K.H., Hutchinson, M.A., Eckhart, W. and Walter, G. (1985) Complexes of polyoma virus medium T antigen and cellular proteins. Proc. Natl Acad. Sci. USA, 82, 7952-7954.
25. Haldar, S., Jena, N. and Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA, 92, 4507-4511.
26. Han, J., Sabbatini, P. and White, E. (1996) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol., 16, 5857-5864.
27. Hanada, M., Aime-Sempe, C., Sato, T. and Reed, J.C. (1995) Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem., 270, 11962-11969.
28. Hengartner, M.O. and Horvitz, H.R. (1994) Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev., 4, 581-586.
29. Hopp, T.P., Prickett, K.S., Price, V.L., Libby, R.T., March, C.J., Cerretti, D.P., Urdal, D.L. and Conlon, P.J. (1988) A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology, 6, 1204-1210.
30. Horton, R.M., Ho, S.N., Pullen, J.K., Hunt, H.D., Cai, Z. and Pease, L.R. (1993) Gene splicing by overlap extension. Methods Enzymol., 217, 270-279.
31. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14. 405-414.
32. Hunter, J.J. and Parslow, T.G. (1996) A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem., 271, 8521-8524.
33. Hunter, J.J., Bond, B.L. and Parslow, T.G. (1996) Functional dissection of the human Bcl2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol., 16, 877-883.
34. Kerr, J.F.R., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
35. Kiefer, M.C., Brauer, M.J., Powers, V.C., Wu, J.J., Umansky, S.R., Tomei, L.D. and Barr, P.J. (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739.
36. Korsmeyer, S.J. (1995) Regulators of cell death. Trends Genet., 11, 101-105.
37. Kumar, S. (1995) ICE-like proteases in apoptosis. Trends Biochem. Sci., 20, 198-202.
38. Lee, L.C., Hunter, J.J., Mujeeb, A., Turck, C. and Parslow, T.G. (1996) Evidence for α-helical conformation of an essential N-terminal region in the human Bcl2 protein. J. Biol. Chem., 271, 23284-23288.
39. Linette, G.P., Hess, J.L., Sentman, C.L. and Korsmeyer, S.J. (1995) Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice. Blood, 86, 1255-1260.
40. Linette, G.P., Li, Y., Roth, K. and Korsmeyer, S.J. (1996) Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl Acad. Sci. USA, 93, 9545-9552.
41. Lipponen, P., Pietilainen, T., Kosma, V.M., Aaltomaa, S., Eskelinen, M. and Syrjanen, K. (1995) Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol., 177, 49-55.
42. Lithgow, T., van Driel, R., Bertram, J.F. and Strasser, A. (1994) The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane. Cell Growth Differ., 5, 411-417.
43. Marvel, J., Perkins, G.R., Lopez-Rivas, A. and Collins, M.K.L. (1994) Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness of IL-3 stimulation of proliferation. Oncogene, 9, 1117-1122.
44. Matolcsy, A., Casali, P., Warnke, R.A. and Knowles, D.M. (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood, 88, 3937-3944.
45. Mazel, S., Burtrum, D. and Petrie, H.T. (1996) Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med., 183, 2219-2226.
46. McDonnell, T.J. and Korsmeyer, S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature, 349, 254-256.
47. L forms an ion channel in synthetic lipid membranes. Nature, 385, 353-357.
48. Mizushima, J. and Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18, 5322.
49. L, an inhibitor of programmed cell death. Nature, 381, 335-341.
50. 2/M. Mol. Cell. Biol., 16, 3884-3892.
51. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139, 271-279.
52. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J.P. and Korsmeyer, S.J. (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol., 144, 3602-3610.
53. O'Reilly, L., Huang, D.C.S. and Strasser, A. (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J., 15, 6979-6990.
54. - T cell progenitors. Int. Immunol., in press.
55. O'Reilly, L.A., Harris, A.W., Tarlinton, D.W., Corcoran, L.M. and Strasser, A. (1997b) Expression of a bcl-2 transgene reduces proliferation and shows turnover of developing B lymphocytes in vivo. J. Immunol., in press.
56. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
57. Pezzella, F., Tse, A.G.D., Cordell, J.L., Pulford, K.A.F., Gatter, K.C. and Mason, D.Y. (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol., 137, 225-232.
58. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6.
59. Sabbatini, P., Chiou, S.K., Rao, L. and White, E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol., 15, 1060-1070.
60. Saez, R., Chan, A.M., Miki, T. and Aaronson, S.A. (1994) Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Oncogene, 9, 2977-2982.
61. L-Bak peptide complex: recognition between regulators of apoptosis. Science, 275, 983-986.
62. Selvakumaran, M., Lin, H.-K., Miyashita, T. Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B. and Liebermann, D. (1994) Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
63. Spector, M.S., Desnoyers, S., Hoeppner, D.J. and Hengartner, M.O. (1997) Interaction between the C.elegans cell-death regulators CED-9 and CED-4. Nature, 385, 653-656.
64. Strasser, A., Harris, A.W., Bath, M.L. and Cory, S. (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature, 348, 331-333.
65. Strasser, A., Harris, A.W. and Cory, S. (1993) Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene, 8, 1-9.
66. Strasser, A., Harris, A.W., Jacks, T. and Cory, S. (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2, Cell, 79, 329-339.
67. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H. and Cory, S. (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14, 6136-6147.
68. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A. and Reed, J.C. (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-284.
69. Tanaka, S., Louie, D.C., Kant, J.A. and Reed, J.C. (1992) Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood, 79, 229-237.
70. Theodorakis, P., D'Sa-Eipper, C., Subramanian, T. and Chinnadurai, G. (1996) Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene, 12, 1707-1713.
71. Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C. and Croce, C.M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science, 226, 1097-1099.
72. Uhlmann, E.J., D'Sa-Eipper, C., Subramanian, T., Wagner, A.J., Hay, N. and Chinnadurai, G. (1996) Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res., 56, 2506-2509.
73. Vairo, G., Innes, K.M. and Adams, J.M. (1996) Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene, 13, 1511-1519.
74. Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
75. Wang, H.-G. et al. (1994) Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene, 9, 2751-2756.
76. Wang, H.-G., Millan, J.A., Cox, A.D., Der, C.J., Rapp, U.R., Beck, T., Zha, H. and Reed, J.C. (1995) R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J. Cell Biol., 129, 1103-1114.
77. Wang, K., Yin, X.-M., Chao, D.T., Milliman, C.L. and Korsmeyer, S.J. (1996) BID: a novel BH3 domain-only death agonist. Genes Dev., 10, 2859-2869.
78. Wang, Y., Okan, I., Pokrovskaja, K. and Wiman, K.G. (1996) Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis. Oncogene, 12, 2731-2735.
79. White, E. (1996) Life, death, and the pursuit of apoptosis. Genes Dev., 10, 1-15.
80. Wu, D., Wallen, H.D. and Nuñez, G. (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9. Science, 275, 1126-1129.
81. Xue, D., Shaham, S. and Horvitz, H.R. (1996) The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev., 10, 1073-1083.
82. Yang, E. and Korsmeyer, S.J. (1996) Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood, 88, 386-401.
83. L and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291.
84. Yin, X.-M., Oltvai, Z.N. and Korsmeyer, S.J. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369, 321-323.
85. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. and Horvitz, H.R. (1993) The C.elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75, 641-652.
86. Zha, H., Aimé-Sempé, C., Sato, T. and Reed, J.C. (1996) Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem., 271, 7440-7444.